During the past couple weeks, as contentious negotiations over spending legislation heated up, then came to a head in the form of a federal government shutdown, two separate announcements from the Trump Administration may have flown under the radar, but are now rippling through the healthcare industry nonetheless: one centered on a dramatic increase in the cost of H-1B visa fees, while the other marked the launch of a new prescription drug pricing platform, TrumpRx.com.
While both initiatives are framed as efforts to protect American jobs and reduce consumer costs, healthcare leaders warn they could have unintended consequences for patient care and access.
President Trump’s recent declaration that a $100,000 fee will now accompany H-1B visa applications has drawn criticism from some healthcare experts and professional societies.
The H-1B visa program has long served as a critical pipeline for foreign-trained medical professionals, particularly in underserved and rural areas, where physician shortages are most severe.
Health systems such as the Mayo Clinic and St. Jude Children’s Research Hospital are among the most frequent users of the H-1B program. These institutions rely on international medical graduates to fill essential roles, especially in specialties and geographic areas with a scarcity of homegrown providers.
In the past year, nearly 17,000 H-1B visas were granted to medical professionals, including surgeons and new medical graduates. And a recent study found that 64 percent of these foreign-trained providers practice in underserved or rural communities, highlighting the program’s importance in addressing healthcare disparities.
The American Medical Association (AMA) and other medical groups have urged the Administration to exempt healthcare workers from the fee increase, saying that the new cost burden could discourage hospitals from sponsoring international physicians, making the current staffing shortages even worse and putting patient care at risk.
In a separate move last week, the Trump Administration unveiled TrumpRx.com, a new platform aimed at helping consumers access lower-priced prescription drugs.
While the announcement has generated interest, there are plenty of questions about what exactly the platform actually does, how it works, and whether its goals are achievable. For example, it’s unclear which medications will be available through TrumpRx.com, or whether consumers will be able to use their insurance to pay for them.
The Administration has positioned the platform as an alternative to traditional pharmacy pricing, wherein consumers can buy drugs directly from manufacturers, bypassing insurance and pharmacy benefit managers (PBMs), but some healthcare analysts are saying that without transparency and the ability to work smoothly with existing payer systems, its impact may be limited.
Initial reactions from industry observers have been mixed. Some see the platform as a step toward greater price competition. Others worry it might actually slow down progress toward a more meaningful fix for the larger prescription drug pricing problem.
Together, the H1-B visa and TrumpRx initiatives underscore the Trump Administration’s broader approach to healthcare policy – one that continues to emphasize cost-cutting and reliance on an American workforce.
In the leadup to the government shutdown, and during the shutdown itself, the Administration isn’t shutting down at all; it’s launching initiatives that may impact the healthcare industry for years to come.
So, as these policies take shape, stay tuned, because stakeholders across the healthcare continuum will be assessing their impact, not just on budgets, but on the quality and accessibility of care for millions of Americans.
In March, the U.S. Supreme Court issued a decision in the case of Chiles v. Salazar. The decision raises many questions and fuels speculation. But
Last summer’s Loper Bright decision was supposed to be a watershed moment for administrative law. By overturning Chevron deference, the U.S. Supreme Court declared that
Please log in to your account to comment on this article.
Breast biopsy procedures may be clinically straightforward but accurately translating them into compliant billing can be anything but. In this focused webcast, Shawn Blackburn, CPC, CPMA, CIC, CRC, CCS-P breaks down how imaging guidance, lesion count, laterality, and payer expectations all impact how these procedures should be reported. Through clear explanations and real-world scenarios, you’ll gain practical insight into aligning clinical workflows with billing requirements, avoiding common pitfalls, and ensuring your documentation supports accurate reimbursement and compliance.
Gain clarity and confidence in OB‑GYN coding with this expert‑led webcast featuring Sherri L. Clayton, RHIT, CSS. You’ll learn how to apply global maternity package rules accurately, select the right CPT codes for procedures and visits, and identify documentation gaps that lead to denials. With practical guidance and real examples, this session helps you strengthen compliance, reduce audit risk, and ensure accurate reimbursement for women’s health services.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Celebrate Lab Week with MedLearn! Sign up to win one year of our Laboratory All Access Pass! Click here to learn more →
Have a Medicare regulation question you’d love Dr. Hirsch to answer? Now is your chance! CLICK HERE to learn more→
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
